drugset / Trial / NCT01453569
Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease
Phase 2
Completed
255 enrolled
Shanghai Greenvalley Pharmaceutical Co., Ltd.
Shanghai Mental Health Center · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary purpose of this study is to determine whether sodium oligo-mannurarate capsule is effective and safe in the treatment of mild to moderate alzheimer' disease, and to determine the best therapeutic dose of sodium oligo-mannurarate capsule.
Timeline
- Start
- 2011-10
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GV-971 | Other / unclassified | 600 mg | Oral |
| Subject | GV-971 | Other / unclassified | 900 mg | Oral |